Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003780211 | SCV004603667 | uncertain significance | Familial aplasia of the vermis; Orofaciodigital syndrome I | 2023-11-25 | criteria provided, single submitter | clinical testing | This sequence change replaces serine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 778 of the OFD1 protein (p.Ser778Ala). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with OFD1-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt OFD1 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004823204 | SCV005462288 | uncertain significance | Primary ciliary dyskinesia | 2024-12-04 | criteria provided, single submitter | clinical testing | The c.2332T>G (p.S778A) alteration is located in exon 17 (coding exon 17) of the OFD1 gene. This alteration results from a T to G substitution at nucleotide position 2332, causing the serine (S) at amino acid position 778 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |